News | Heron Neutron Medical Corp.

2026-03-26

HERON Receives TFDA Approval for BNCT Treatment Planning System

HERON Advances Neutron Irradiation System TFDA Approval Now Covers BNCT Treatment Planning System, Completing the Precision Medicine Ecosystem

News

2026-01-29

HERON Neutron Medical and Siemens Healthineers Join Forces to Build an AI-Driven AB-BNCT Integrated Theranostics Platform, Pioneering a New Era of Precision Radiation Oncology

HERON Neutron Medical Corp., a global leader in Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT), today announced the signing of a strategic cooperation agreement with Siemens Healthineers, a world-leading medical imaging company. The two parties will establish a strategic partnership combining AB-BNCT treatment technology with state-of-the-art imaging platforms to jointly develop an AI-driven “theranostics” integrated platform, ushering precision radiation oncology into a new milestone.

01 02

News

2026-03-27

Head and Neck Cancer Association Hosts Seminar on BNCT and Emerging Trends in Precision Radiotherapy

News

2026-03-09

HERON Neutron Medical and PELL Bio-Med Sign MOU for Strategic Alliance

News

2026-01-07

NYCU, Heron Neutron Medical Corp, and Chuming Foundation Sign MOU to Establish "BNCT and Advanced Imaging Center"

News

2025-12-19

Heron Partners with National University Hospital and A*STAR to Establish Southeast Asia's First AB-BNCT Research Centre

News

2025-12-04

Taiwan-Developed AB-BNCT Technology Showcased at 2025 Healthcare Expo; President Lai Visits Heron Neutron Booth

News

2025-09-15

Heron Neutron Lists on the Stock Market, Opening New Chapter in Cancer Treatment

News

2025-08-26

Heron Partners with Qisda Group to Establish BNCT Center and Expand Overseas

News

2025-08-18

Groundbreaking Ceremony for Taipei Veterans General Hospital BNCT Center: Taiwan Advances Toward World-Class Cancer Treatment

News

2025-07-21

Heron Neutron Medical Corp.– Clinical Trial Recruitment Notice Unresectable Recurrent Head and Neck Cancers for Patients in Boron Neutron Capture Therapy (BNCT)

Contact

If you have any questions, please feel free to contact us.

新聞

Innovative Treatment Options by AB-BNCT Patients Cured and Maintain Quality of Life

HERON Receives TFDA Approval for BNCT Treatment Planning System

HERON Neutron Medical and Siemens Healthineers Join Forces to Build an AI-Driven AB-BNCT Integrated Theranostics Platform, Pioneering a New Era of Precision Radiation Oncology

Head and Neck Cancer Association Hosts Seminar on BNCT and Emerging Trends in Precision Radiotherapy

HERON Neutron Medical and PELL Bio-Med Sign MOU for Strategic Alliance

NYCU, Heron Neutron Medical Corp, and Chuming Foundation Sign MOU to Establish "BNCT and Advanced Imaging Center"

Heron Partners with National University Hospital and A*STAR to Establish Southeast Asia's First AB-BNCT Research Centre

Taiwan-Developed AB-BNCT Technology Showcased at 2025 Healthcare Expo; President Lai Visits Heron Neutron Booth

Heron Neutron Lists on the Stock Market, Opening New Chapter in Cancer Treatment

Heron Partners with Qisda Group to Establish BNCT Center and Expand Overseas

Groundbreaking Ceremony for Taipei Veterans General Hospital BNCT Center: Taiwan Advances Toward World-Class Cancer Treatment

Heron Neutron Medical Corp.– Clinical Trial Recruitment Notice Unresectable Recurrent Head and Neck Cancers for Patients in Boron Neutron Capture Therapy (BNCT)

Contact